Pages that link to "Q71762882"
Jump to navigation
Jump to search
The following pages link to Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape (Q71762882):
Displaying 50 items.
- BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth (Q22009942) (← links)
- Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1 (Q22010439) (← links)
- Inhibition of Daxx-mediated apoptosis by heat shock protein 27 (Q24290301) (← links)
- TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. (Q24314730) (← links)
- APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth (Q24315058) (← links)
- Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells (Q24316364) (← links)
- Inhibition of death receptor signals by cellular FLIP (Q24316446) (← links)
- TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95) (Q24323902) (← links)
- Natural selection of tumor variants in the generation of "tumor escape" phenotypes (Q24551158) (← links)
- Fas-ligand: privilege and peril (Q24612227) (← links)
- Identification of amino acid residues important for ligand binding to Fas (Q24669797) (← links)
- Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain (Q24676619) (← links)
- Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer (Q24793123) (← links)
- Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment (Q24794258) (← links)
- FADD adaptor in cancer (Q24795895) (← links)
- Gene therapy for carcinoma of the breast: Genetic immunotherapy (Q24797848) (← links)
- Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer (Q24801183) (← links)
- Transfer of efficient anti-melanocyte T cells from vitiligo donors to melanoma patients as a novel immunotherapeutical strategy (Q24814910) (← links)
- Fas ligand expression in human and mouse cancer cell lines; a caveat on over-reliance on mRNA data. (Q25256768) (← links)
- The cancer stem cell: evidence for its origin as an injured autoreactive T cell (Q25256839) (← links)
- Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression (Q26775189) (← links)
- Role of apoptosis in disease (Q26865637) (← links)
- Fas-Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis (Q28074658) (← links)
- The Akt-regulated Forkhead Transcription Factor FOXO3a Controls Endothelial Cell Viability through Modulation of the Caspase-8 Inhibitor FLIP (Q28208798) (← links)
- TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL (Q28248106) (← links)
- Apoptosis by death factor (Q28304002) (← links)
- Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis (Q28344462) (← links)
- Tumor cells express FcgammaRI which contributes to tumor cell growth and a metastatic phenotype (Q28367459) (← links)
- Paclitaxel-induced apoptosis in non-small cell lung cancer cell lines is associated with increased caspase-3 activity (Q28374373) (← links)
- Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death (Q28570235) (← links)
- Regulation of Fas ligand expression and cell death by apoptosis-linked gene 4 (Q28592335) (← links)
- Immunosuppressive strategies that are mediated by tumor cells (Q29636247) (← links)
- Hepatocyte nuclear factor (HNF)-4alpha induces expression of endothelial Fas ligand (FasL) to prevent cancer cell transmigration: a novel defense mechanism of endothelium against cancer metastasis (Q30273613) (← links)
- Vaccination for melanoma (Q30306588) (← links)
- Fas engagement increases expression of interleukin-6 in human glioma cells (Q30831799) (← links)
- Overexpression of Fas-ligand by neuroblastoma: a novel mechanism of tumor-cell killing (Q30842527) (← links)
- Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L (Q32152397) (← links)
- Advances in apoptosis research (Q32181116) (← links)
- Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis. (Q33183537) (← links)
- CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants (Q33195823) (← links)
- Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma. (Q33284046) (← links)
- p53/T-antigen complex disruption in T-antigen transformed NIH3T3 fibroblasts exposed to oxidative stress: correlation with the appearance of a Fas/APO-1/CD95 dependent, caspase independent, necrotic pathway (Q33289426) (← links)
- Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden. (Q33530092) (← links)
- Apoptosis of activated peripheral T cells (Q33541433) (← links)
- The Fas counterattack: cancer as a site of immune privilege (Q33542332) (← links)
- Impediments to successful immunotherapy (Q33586651) (← links)
- Is extravasation a Fas-regulated process? (Q33592542) (← links)
- The role of Fas and related death receptors in autoimmune and other disease states (Q33636111) (← links)
- Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4(+) and CD8(+) antiviral T cells by viral antigen-positive veto cells. (Q33646733) (← links)
- Control of tumor development by intratumoral cytokines (Q33682317) (← links)